Exane Derivatives Amgen Inc Transaction History

Exane Derivatives

$157 Million
Q2 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $2.56 Million - $2.85 Million	-11,095 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $1.66 Million - $1.83 Million	7,551 Added 213.06%	11,095 $2.68 Million
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $630,250 - $721,264	3,169 Added 845.07%	3,544 $797,000
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $78,752 - $92,267	371 Added 9275.0%	375 $79,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $934 - $1,036	4 New	4 $0
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $166,210 - $193,691	-749 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $48,901 - $58,233	226 Added 43.21%	749 $172,000
Q3 2020 Oct 06, 2020	SELL	$234.65 - $260.95 $2.12 Million - $2.36 Million	-9,047 Reduced 94.54%	523 $132,000
Q2 2020 Jul 10, 2020	BUY	$197.81 - $242.74 $1.77 Million - $2.18 Million	8,969 Added 1492.35%	9,570 $2.26 Million
Q4 2019 Jan 22, 2020	SELL	$189.21 - $243.2 $27,813 - $35,750	-147 Reduced 19.65%	601 $144,000
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $124,691 - $146,166	748 New	748 $0
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $93,328 - $105,202	-516 Closed	0 $0
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $773,029 - $871,489	-4,172 Reduced 88.99%	516 $0
Q2 2018 Oct 24, 2018	BUY	$166.05 - $186.51 $778,442 - $874,358	4,688 New	4,688 $0
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $759,678 - $853,283	-4,575 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $105,385 - $123,156	622 Added 15.73%	4,575 $0
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $599,710 - $670,060	3,553 Added 888.25%	3,953 $0
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $66,916 - $76,400	400	400 $0

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account